Middle East and Africa Cell Therapy Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Therapy Type (Allogeneic, Autologous); Product (Consumables, Equipment, Systems and Software); Technology (Viral Vector Technology, Genome Editing Technology, Somatic Cell Technology, Cell Immortalization Technology, Cell Plasticity Technology, Three-dimensional Technology); Application (Oncology, Cardiovascular, Orthopedic, Wound Management, Other Applications); End User (Research Institutes, Hospitals, Others) and Country
Market Introduction
Cell therapy is a procedure where living and intact cells are injected, implanted, or grafted into the patient's body. This technology relies on replacing dysfunctional cells with healthy functioning ones. Cells mainly used for such advanced therapies are stem cells, because of their ability to differentiate into the specific cells required for repairing damaged or defective tissues or cells. Moreover, cell therapy also has applications in the development of regenerative medicines.
Market Dynamics
The Middle East and Africa cell therapy market is expected to reach US$ 346.7 million by 2027 from US$ 234.4 million in 2019; it is anticipated to grow at a CAGR of 5.1% during 2019–2027. Factors such as increasing prevalence of chronic diseases, rising adoption of regenerative medicines and increasing number of approvals for cell-based therapies are expected to boost the growth of the cell therapy market in the coming years. However, the market is likely to get impacted by the risk factor such as high cost of cell therapy manufacturing, during the forecast period.
COVID-19 pandemic has become the most significant challenge across the Middle East and Africa region. Countries such as UAE, and Saudi Arabia have also registered a significant number of positive patients. Therefore, countries have faced several challenges for their requirements. Initial phase of lockdown in various countries has affected the supply of many instruments in these regions. Therefore, many organizations are collaborating with others to overcome this pandemic by using cell therapies for the treatment of COVID 19. For instance, United Arab Emirates-based Abu Dhabi Stem Cells Center (ADSCC) has entered into collaboration agreement with Pluristem Therapeutics Inc. to develop cell therapies and regenerative medicines for the treatment of COVID-19.
Market Scope
The scope of the Middle East and Africa cell therapy market includes therapy type, product, technology, applications, end user and countries. In terms of therapy type, the allogeneic segment accounted for the largest share of the Middle East and Africa cell therapy market in 2019. In terms of product, the consumables segment accounted for the largest share of the Middle East and Africa cell therapy market in 2019. The viral vector technology segment accounted for the largest share of the Middle East and Africa cell therapy market, by technology, in 2019. In terms of applications, the Oncology segment accounted for the largest share of the Middle East and Africa cell therapy market in 2019. In terms of end user, the Research Institutes segment accounted for the largest share of the Middle East and Africa cell therapy market in 2019.
Major Sources and Companies Listed
Several major primary and secondary sources associated with the Middle East and Africa cell therapy market report are the World Health Organization (WHO), Centers of Disease Control and Prevention (CDC), National Institute of Health of South Africa, and Department of Health Abu Dhabi, Abu Dhabi Stem Cell Center (ADSCC) and among others.
Reasons to Buy Report
- It provides understanding of the Middle East and Africa, cell therapy market landscape and identifies cell therapy market segments that are most likely to guarantee a strong return.
- It guides stay ahead of the race by comprehending the ever-changing competitive landscape for the Middle East and Africa cell therapy market.
- It helps efficiently plan merger and acquisition, and partnership deals in the cell therapy market by identifying market segments with the most promising probable sales.
- It facilitates knowledgeable business decision-making through perceptive and comprehensive analysis of cell therapy market performance of various segments pertaining to the Middle East and Africa cell therapy market.
- It provides cell therapy market revenue forecast of the market based on various segments for the period from 2019 to 2027.
MIDDLE EAST AND AFRICA CELL THERAPY MARKET SEGMENTATION
By Therapy Type
- Allogeneic
- Autologous
By Product
- Consumables
- Equipment
- Systems and Software
By Technology
- Viral Vector Technology
- Genome Editing Technology
- Somatic Cell Technology
- Cell Immortalization Technology
- Cell Plasticity Technology
- Three-dimensional Technology
By Application
- Oncology
- Cardiovascular
- Orthopedic
- Wound Management
- Other Applications
By End User
- Research Institutes
- Hospitals
- Others
By Country
- Saudi Arabia
- UAE
- South Africa
Company Profiles
- NuVasive, Inc.
- Smith & Nephew
- Bristol-Myers Squibb Company
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Middle East and Africa Cell Therapy Market – By Therapy Type
1.3.2 Middle East and Africa Cell Therapy Market – By Product
1.3.3 Middle East and Africa Cell Therapy Market – By Technology
1.3.4 Middle East and Africa Cell Therapy Market – By Application
1.3.5 Middle East and Africa Cell Therapy Market – By End User
1.3.6 Middle East and Africa Cell Therapy market – By Countries
2. Middle East and Africa Cell Therapy Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Middle East and Africa Cell Therapy Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Cell Therapy Market - Middle East and Africa PEST Analysis
4.3 Expert Opinion
5. Middle East and Africa Cell Therapy Market - Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Increasing Prevalence of Chronic Diseases
5.1.2 Rising Adoption of Regenerative Medicines
5.1.3 Increasing Number of Approvals for Cell-Based Therapies
5.2 Key Market Restraints
5.2.1 High Cost of Cell Therapy Manufacturing
5.3 Key Market Opportunities
5.3.1 Increasing Adoption of Cell Therapy in Middle East Regions
5.4 Future Trends
5.4.1 Shift Toward Automated Cell Therapy Manufacturing
5.5 Impact Analysis of Drivers and Restraints
6. Cell Therapy Market – Middle East and Africa Analysis
6.1 Middle East and Africa Cell Therapy Market Revenue Forecast And Analysis
6.2 Middle East and Africa Cell Therapy Market, By Countries - Forecast And Analysis
6.3 Market Positioning of Key Players
7. Middle East and Africa Cell Therapy Market Analysis – By Therapy Type
7.1 Overview
7.2 Middle East and Africa Cell Therapy Market Revenue Share, by Therapy Type (2019 and 2027)
7.3 Allogeneic
7.3.1 Overview
7.3.1.1 Allogeneic: Middle East and Africa Cell Therapy Market– Revenue and Forecast to 2027 (US$ million)
7.4 Autologous
7.4.1 Overview
7.4.1.1 Autologous: Middle East and Africa Cell Therapy Market– Revenue and Forecast to 2027 (US$ million)
8. Middle East and Africa Cell Therapy Market Analysis – By Product
8.1 Overview
8.2 Cell Therapy Market Revenue Share, by Product (2019 and 2027)
8.3 Consumables
8.3.1 Overview
8.3.1.1 Consumables: Cell Therapy Market Market– Revenue and Forecast to 2027 (US$ million)
8.4 Equipment
8.4.1 Overview
8.4.1.1 Equipment: Cell Therapy Market Market– Revenue and Forecast to 2027 (US$ million)
8.5 Systems and Software
8.5.1 Overview
8.5.1.1 Systems and Software: Cell Therapy Market Market– Revenue and Forecast to 2027 (US$ million)
9. Middle East and Africa Cell Therapy Market Analysis – By Technology
9.1 Overview
9.2 Middle East and Africa Cell Therapy Market Share, by Technology, 2019 and 2027, (%)
9.3 Viral vector Technology
9.3.1 Overview
9.3.1.1 Viral vector Technology: Cell Therapy Market Market– Revenue and Forecast to 2027 (US$ million)
9.4 Genome Editing Technology
9.4.1 Overview
9.4.1.1 Genome Editing Technology: Cell Therapy Market Market– Revenue and Forecast to 2027 (US$ million)
9.5 Somatic Cell Technology
9.5.1 Overview
9.5.1.1 Somatic Cell Technology: Cell Therapy Market Market– Revenue and Forecast to 2027 (US$ million)
9.6 Cell Immortalization Technology
9.6.1 Overview
9.6.2 Cell Immortalization Technology: Cell therapy Market – Revenue and Forecast to 2027 (US$ Million)
9.7 Cell Plasticity Technology
9.7.1 Overview
9.7.2 Cell Plasticity Technology: Cell therapy Market – Revenue and Forecast to 2027 (US$ Million)
9.8 Three-Dimensional Technology
9.8.1 Overview
9.8.2 Three-Dimensional Technology: Cell therapy Market – Revenue and Forecast to 2027 (US$ Million)
10. Middle East and Africa cell therapy market Analysis – By Application
10.1 Overview
10.2 Middle East and Africa cell therapy market Revenue Share, by Application (2019 and 2027)
10.3 Oncology
10.3.1 Overview
10.3.2 Oncology: Middle East and Africa cell therapy market – Revenue and Forecast to 2027 (US$ Million)
10.4 Cardiovascular
10.4.1 Overview
10.4.2 Cardiovascular: Middle East and Africa cell therapy market – Revenue and Forecast to 2027 (US$ Million)
10.5 Orthopedic
10.5.1 Overview
10.5.2 Orthopedic: Middle East and Africa cell therapy market – Revenue and Forecast to 2027 (US$ Million)
10.6 Wound Management
10.6.1 Overview
10.6.2 Wound Management: Middle East and Africa cell therapy market – Revenue and Forecast to 2027 (US$ Million)
10.7 Other Applications
10.7.1 Overview
10.7.2 Other Applications: Middle East and Africa cell therapy market – Revenue and Forecast to 2027 (US$ Million)
11. Middle East and Africa cell therapy market Analysis – By End User
11.1 Overview
11.2 Middle East and Africa cell therapy market Share, by End User, 2019 and 2027, (%)
11.3 Hospitals
11.3.1 Overview
11.3.2 Hospitals: Middle East and Africa cell therapy market – Revenue and Forecast to 2027 (US$ Million)
11.4 Research Institutes
11.4.1 Overview
11.4.2 Research Institutes: Middle East and Africa cell therapy market – Revenue and Forecast to 2027 (US$ Million)
11.5 Others
11.5.1 Overview
11.5.2 Others: Middle East and Africa cell therapy market – Revenue and Forecast to 2027 (US$ Million)
12. Middle East and Africa Cell Therapy Market Analysis And Forecasts To 2027 – Regional Analysis
12.1 Middle East and Africa: Cell Therapy Market
12.1.1 Overview
12.1.2 Middle East and Africa: Cell Therapy Market - Revenue and Forecast to 2027 (USD Million)
12.1.3 Middle East and Africa: Cell Therapy Market, by Therapy Type, 2018–2027 (USD Millions)
12.1.4 Middle East and Africa: Cell Therapy Market, by Product, 2018–2027 (USD Millions)
12.1.5 Middle East and Africa: Cell Therapy Market, by Technology, 2018–2027 (USD Million)
12.1.6 Middle East and Africa: Cell Therapy Market, by Application, 2018–2027 (USD Million)
12.1.7 Middle East and Africa: Cell Therapy Market, by End-User, 2018–2027 (USD Million)
12.1.8 Middle East and Africa: Cell Therapy Market, by Country, 2019& 2027 (%)
12.1.9 UAE: Cell Therapy Market – Revenue and Forecast to 2027 (USD Million)
12.1.9.1 UAE: Cell Therapy Market – Revenue and Forecast to 2027 (USD Million)
12.1.9.2 UAE: Cell Therapy Market, by Therapy Type, 2018–2027 (USD Millions)
12.1.9.3 UAE: Cell Therapy Market, by Product, 2018–2027 (USD Millions)
12.1.9.4 UAE: Cell Therapy Market, by Technology, 2018–2027 (USD Million)
12.1.9.5 UAE: Cell Therapy Market, by Application, 2018–2027 (USD Million)
12.1.9.6 UAE: Cell Therapy Market, by End User, 2018–2027 (USD Million)
12.1.10 Saudi Arabia: Cell Therapy Market – Revenue and Forecast to 2027 (USD Million)
12.1.10.1 Saudi Arabia: Cell Therapy Market – Revenue and Forecast to 2027 (USD Million)
12.1.10.2 Saudi Arabia: Cell Therapy Market, by Therapy Type, 2018–2027 (USD Millions)
12.1.10.3 Saudi Arabia: Cell Therapy Market, by Product, 2018–2027 (USD Millions)
12.1.10.4 Saudi Arabia: Cell Therapy Market, by Technology, 2018–2027 (USD Millions)
12.1.10.5 Saudi Arabia: Cell Therapy Market, by Application, 2018–2027 (USD Million)
12.1.10.6 Saudi Arabia: Cell Therapy Market, by End User, 2018–2027 (USD Million)
12.1.11 South Africa: Cell Therapy Market – Revenue and Forecast to 2027 (USD Million)
12.1.11.1 South Africa: Cell Therapy Market – Revenue and Forecast to 2027 (USD Million)
12.1.11.2 South Africa: Cell Therapy Market, by Therapy Type, 2018–2027 (USD Millions)
12.1.11.3 South Africa: Cell Therapy Market, by Product, 2018–2027 (USD Million)
12.1.11.4 South Africa: Cell Therapy Market, by Technology, 2018–2027 (USD Million)
12.1.11.5 South Africa: Cell Therapy Market, by Application, 2018–2027 (USD Million)
12.1.11.6 South Africa: Cell Therapy Market, by End User, 2018–2027 (USD Million)
13. Impact of COVID-19 Pandemic on Middle East and Africa Cell Therapy Market
13.1 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
14. Company Profiles
14.1 NuVasive, Inc.
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Smith & Nephew
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Bristol-Myers Squibb Company
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms
LIST OF TABLES
Table 1. Middle East and Africa Cell Therapy Market, by Therapy Type – Revenue and Forecast to 2027 (USD Millions)
Table 2. Middle East and Africa Cell Therapy Market, by Product – Revenue and Forecast to 2027 (USD Millions)
Table 3. Middle East and Africa Cell Therapy Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 4. Middle East and Africa Cell Therapy Market, by Application– Revenue and Forecast to 2027 (USD Million)
Table 5. Middle East and Africa Cell Therapy Market, by End-User – Revenue and Forecast to 2027 (USD Million)
Table 6. UAE Cell Therapy Market, by Therapy Type – Revenue and Forecast to 2027 (USD Millions)
Table 7. UAE Cell Therapy Market, by Product – Revenue and Forecast to 2027 (USD Millions)
Table 8. UAE Cell Therapy Market, by Technology, – Revenue and Forecast to 2027 (USD Million)
Table 9. UAE Cell Therapy Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 10. UAE Cell Therapy Market, by End User– Revenue and Forecast to 2027 (USD Million)
Table 11. Saudi Arabia Cell Therapy Market, by Therapy Type – Revenue and Forecast to 2027 (USD Millions)
Table 12. Saudi Arabia Cell Therapy Market, by Product– Revenue and Forecast to 2027 (USD Millions)
Table 13. Saudi Arabia Cell Therapy Market, by Technology – Revenue and Forecast to 2027 (USD Millions)
Table 14. Saudi Arabia Cell Therapy Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 15. Saudi Arabia Cell Therapy Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 16. South Africa Cell Therapy Market, by Therapy Type – Revenue and Forecast to 2027 (USD Millions)
Table 17. South Africa Cell Therapy Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 18. South Africa Cell Therapy Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 19. South Africa Cell Therapy Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 20. South Africa Cell Therapy Market, by End User– Revenue and Forecast to 2027 (USD Million)
Table 21. Glossary of Terms, Cell Therapy Market
LIST OF FIGURES
Figure 1. Cell Therapy Market Segmentation
Figure 2. Middle East and Africa Cell Therapy Market Segmentation – By Countries
Figure 3. Middle East and Africa Cell Therapy Market Overview
Figure 4. Allogeneic Therapy Type Segment Held Largest Share of Middle East and Africa Cell Therapy Market
Figure 5. Cell Therapy Market - Middle East and Africa PEST Analysis
Figure 6. Middle East and Africa Cell Therapy Market Impact Analysis of Drivers and Restraint
Figure 7. Middle East and Africa Cell Therapy Market – Revenue Forecast And Analysis – 2019- 2027 (US$ Million)
Figure 8. Middle East and Africa Cell Therapy Market – By Countries Forecast and Analysis – 2019- 2027
Figure 9. Market Positioning Of Key Players In Middle East and Africa Cell Therapy Market
Figure 10. Middle East and Africa Cell Therapy Market Revenue Share, by Therapy Type (2019 and 2027)
Figure 11. Allogeneic: Middle East and Africa Cell Therapy Market– Revenue and Forecast to 2027 (US$ million)
Figure 12. Autologous: Middle East and Africa Cell Therapy Market– Revenue and Forecast to 2027 (US$ million)
Figure 13. Cell Therapy Market Revenue Share, by Product (2019 and 2027)
Figure 14. Consumables: Cell Therapy Market Market– Revenue and Forecast to 2027 (US$ million)
Figure 15. Equipment: Cell Therapy Market Market– Revenue and Forecast to 2027 (US$ million)
Figure 16. Systems and Software: Cell Therapy Market Market– Revenue and Forecast to 2027 (US$ million)
Figure 17. Middle East and Africa Cell Therapy Market Share, by technology, 2019 and 2027 (%)
Figure 18. Viral vector Technology: Cell Therapy Market Market– Revenue and Forecast to 2027 (US$ million)
Figure 19. Genome Editing Technology: Cell Therapy Market Market– Revenue and Forecast to 2027 (US$ million)
Figure 20. Somatic Cell Technology: Cell Therapy Market Market– Revenue and Forecast to 2027 (US$ million)
Figure 21. Cell Immortalization Technology: Cell therapy Market – Revenue and Forecast to 2027 (US$ Million)
Figure 22. Cell Plasticity Technology: Cell therapy Market – Revenue and Forecast to 2027 (US$ Million)
Figure 23. Three-Dimensional Technology: Cell therapy Market – Revenue and Forecast to 2027 (US$ Million)
Figure 24. Middle East and Africa cell therapy market Revenue Share, by Application (2019 and 2027)
Figure 25. Oncology: Middle East and Africa cell therapy market – Revenue and Forecast to 2027 (US$ Million)
Figure 26. Cardiovascular: Middle East and Africa cell therapy market – Revenue and Forecast to 2027 (US$ Million)
Figure 27. Orthopedic: Middle East and Africa cell therapy market – Revenue and Forecast to 2027 (US$ Million)
Figure 28. Wound Management: Middle East and Africa cell therapy market – Revenue and Forecast to 2027 (US$ Million)
Figure 29. Other Applications: Middle East and Africa cell therapy market – Revenue and Forecast to 2027 (US$ Million)
Figure 30. Middle East and Africa cell therapy market Share, by End User, 2019 and 2027 (%)
Figure 31. Hospitals Middle East and Africa cell therapy market – Revenue and Forecast to 2027 (US$ Million)
Figure 32. Research Institutes: Middle East and Africa cell therapy market – Revenue and Forecast to 2027 (US$ Million)
Figure 33. Others: Middle East and Africa cell therapy market – Revenue and Forecast to 2027 (US$ Million)
Figure 34. Middle East and Africa: Cell Therapy Market, by Key Country – Revenue (2019) (USD Million)
Figure 35. Middle East and Africa Cell Therapy Market Revenue and Forecast to 2027 (USD Millions)
Figure 36. UAE: Cell Therapy Market – Revenue and Forecast to 2027 (USD Million)
Figure 37. Saudi Arabia: Cell Therapy Market – Revenue and Forecast to 2027 (USD Million)
Figure 38. South Africa: Cell Therapy Market – Revenue and Forecast to 2027 (USD Million)
Figure 39. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets
- NuVasive, Inc.
- Smith & Nephew
- Bristol-Myers Squibb Company
- It provides understanding of the Middle East and Africa, cell therapy market landscape and identifies cell therapy market segments that are most likely to guarantee a strong return.
- It guides stay ahead of the race by comprehending the ever-changing competitive landscape for the Middle East and Africa cell therapy market.
- It helps efficiently plan merger and acquisition, and partnership deals in the cell therapy market by identifying market segments with the most promising probable sales.
- It facilitates knowledgeable business decision-making through perceptive and comprehensive analysis of cell therapy market performance of various segments pertaining to the Middle East and Africa cell therapy market.
- It provides cell therapy market revenue forecast of the market based on various segments for the period from 2019 to 2027.